NASDAQ:KURA

Kura Oncology Stock Insider Trading

etoro logo Buy KURA
*Your capital is at risk
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026

Kura Oncology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 31.90. In total, the insiders bought 3.99M and sold 291.61K KURA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
31.90
Buy 3.99M shares
Sell 291.61K shares
57% Buy Activity
Moderate Positive Correlation
Sell Signal Low Confidence
May 21, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 31.9.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 13, 2025
Buy
Common Stock
A-Award
Doyle Thomas James
SVP, Finance & Accounting
Officer 24 967
Value: $266.6K
Nov 13, 2025
Buy
Common Stock
A-Award
Ford Kathleen
Chief Operating Officer
C-Suite Officer 48 900
Value: $522.3K
Sep 29, 2025
Sell
Common Stock
S-Sale
Powl Brian T.
Chief Commercial Officer
Officer 8 891
Value: $79.5K
Sep 29, 2025
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 8 805
Value: $78.7K
Sep 29, 2025
Sell
Common Stock
S-Sale
Ford Kathleen
Chief Operating Officer
C-Suite Officer 6 892
Value: $61.6K
Sep 29, 2025
Sell
Common Stock
S-Sale
Leoni Mollie
Chief Medical Officer
Officer 12 314
Value: $110.1K
Sep 29, 2025
Sell
Common Stock
S-Sale
Wilson Troy Edward
President And CEO
CEO / President 36 615
Value: $327.4K
Sep 29, 2025
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 4 541
Value: $40.6K
Sep 29, 2025
Sell
Common Stock
S-Sale
Doyle Thomas James
SVP, Finance & Accounting
Officer 4 541
Value: $40.6K
Sep 29, 2025
Sell
Common Stock
S-Sale
Wilson Troy Edward
President And CEO
CEO / President 36 615
Value: $327.4K
Sep 29, 2025
Sell
Common Stock
S-Sale
Leoni Mollie
Chief Medical Officer
Officer 12 314
Value: $110.1K
Sep 29, 2025
Sell
Common Stock
S-Sale
Ford Kathleen
Chief Operating Officer
C-Suite Officer 6 892
Value: $61.6K
Sep 29, 2025
Sell
Common Stock
S-Sale
Bair Teresa Brophy
Chief Legal Officer
Officer 8 805
Value: $78.7K
Sep 29, 2025
Sell
Common Stock
S-Sale
Powl Brian T.
Chief Commercial Officer
Officer 8 891
Value: $79.5K
Sep 27, 2025
Buy
Common Stock
A-Award
Powl Brian T.
Chief Commercial Officer
Officer 48 900
Value: $423.2K
Sep 27, 2025
Buy
Common Stock
A-Award
Bair Teresa Brophy
Chief Legal Officer
Officer 48 900
Value: $423.2K
Sep 27, 2025
Buy
Common Stock
A-Award
Ford Kathleen
Chief Operating Officer
C-Suite Officer 48 900
Value: $423.2K
Sep 27, 2025
Buy
Common Stock
A-Award
Leoni Mollie
Chief Medical Officer
Officer 82 500
Value: $714.0K
Sep 27, 2025
Buy
Common Stock
A-Award
Wilson Troy Edward
President And CEO
CEO / President 182 500
Value: $1.58M
Sep 27, 2025
Buy
Common Stock
A-Award
Doyle Thomas James
SVP, Finance & Accounting
Officer 24 966
Value: $216.1K
Sep 27, 2025
Buy
Common Stock
A-Award
Doyle Thomas James
SVP, Finance & Accounting
Officer 24 966
Value: $216.1K
Sep 27, 2025
Buy
Common Stock
A-Award
Wilson Troy Edward
President And CEO
CEO / President 182 500
Value: $1.58M
Sep 27, 2025
Buy
Common Stock
A-Award
Leoni Mollie
Chief Medical Officer
Officer 82 500
Value: $714.0K
Sep 27, 2025
Buy
Common Stock
A-Award
Ford Kathleen
Chief Operating Officer
C-Suite Officer 48 900
Value: $423.2K
Sep 27, 2025
Buy
Common Stock
A-Award
Bair Teresa Brophy
Chief Legal Officer
Officer 48 900
Value: $423.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KURA ONCOLOGY
Kura Oncology
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE